184 related articles for article (PubMed ID: 26899498)
1. A beacon of hope in stroke therapy-Blockade of pathologically activated cellular events in excitotoxic neuronal death as potential neuroprotective strategies.
Hoque A; Hossain MI; Ameen SS; Ang CS; Williamson N; Ng DC; Chueh AC; Roulston C; Cheng HC
Pharmacol Ther; 2016 Apr; 160():159-79. PubMed ID: 26899498
[TBL] [Abstract][Full Text] [Related]
2. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
Lipton SA
J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
[TBL] [Abstract][Full Text] [Related]
3. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.
Lipton SA
Curr Drug Targets; 2007 May; 8(5):621-32. PubMed ID: 17504105
[TBL] [Abstract][Full Text] [Related]
4. Excitotoxicity and stroke: identifying novel targets for neuroprotection.
Lai TW; Zhang S; Wang YT
Prog Neurobiol; 2014 Apr; 115():157-88. PubMed ID: 24361499
[TBL] [Abstract][Full Text] [Related]
5. The chemical biology of clinically tolerated NMDA receptor antagonists.
Chen HS; Lipton SA
J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of intranasally administered nanoparticles-mediated neuroprotective peptide NR2B9c to brain and neuron for treatment of ischemic stroke.
Li R; Huang Y; Chen L; Zhou H; Zhang M; Chang L; Shen H; Zhou M; Su P; Zhu D
Nanomedicine; 2019 Jun; 18():380-390. PubMed ID: 30428334
[TBL] [Abstract][Full Text] [Related]
7. Memantine for the Treatment of Dementia: A Review on its Current and Future Applications.
Folch J; Busquets O; Ettcheto M; Sánchez-López E; Castro-Torres RD; Verdaguer E; Garcia ML; Olloquequi J; Casadesús G; Beas-Zarate C; Pelegri C; Vilaplana J; Auladell C; Camins A
J Alzheimers Dis; 2018; 62(3):1223-1240. PubMed ID: 29254093
[TBL] [Abstract][Full Text] [Related]
8. In vitro evidence for post-insult neuroprotective activity of an evolutionarily conserved motif against excitotoxic neuronal cell death.
Tran PV
Neuroreport; 2019 Feb; 30(3):213-216. PubMed ID: 30649102
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
Lipton SA; Gu Z; Nakamura T
Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective and anti-inflammatory roles of the phosphatase and tensin homolog deleted on chromosome Ten (PTEN) Inhibition in a Mouse Model of Temporal Lobe Epilepsy.
Grande V; Manassero G; Vercelli A
PLoS One; 2014; 9(12):e114554. PubMed ID: 25501575
[TBL] [Abstract][Full Text] [Related]
11. N-Terminomic Changes in Neurons During Excitotoxicity Reveal Proteolytic Events Associated With Synaptic Dysfunctions and Potential Targets for Neuroprotection.
Ameen SS; Griem-Krey N; Dufour A; Hossain MI; Hoque A; Sturgeon S; Nandurkar H; Draxler DF; Medcalf RL; Kamaruddin MA; Lucet IS; Leeming MG; Liu D; Dhillon A; Lim JP; Basheer F; Zhu HJ; Bokhari L; Roulston CL; Paradkar PN; Kleifeld O; Clarkson AN; Wellendorph P; Ciccotosto GD; Williamson NA; Ang CS; Cheng HC
Mol Cell Proteomics; 2023 May; 22(5):100543. PubMed ID: 37030595
[TBL] [Abstract][Full Text] [Related]
12. The Neuroprotective Peptide Poly-Arginine-12 (R12) Reduces Cell Surface Levels of NMDA NR2B Receptor Subunit in Cortical Neurons; Investigation into the Involvement of Endocytic Mechanisms.
MacDougall G; Anderton RS; Edwards AB; Knuckey NW; Meloni BP
J Mol Neurosci; 2017 Feb; 61(2):235-246. PubMed ID: 27866326
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy in ischemic stroke: synergistic neuroprotective effects of memantine and clenbuterol.
Culmsee C; Junker V; Kremers W; Thal S; Plesnila N; Krieglstein J
Stroke; 2004 May; 35(5):1197-202. PubMed ID: 15060319
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity.
Volbracht C; van Beek J; Zhu C; Blomgren K; Leist M
Eur J Neurosci; 2006 May; 23(10):2611-22. PubMed ID: 16817864
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of taurine protection against endoplasmic reticulum stress in an animal stroke model of cerebral artery occlusion and stroke-related conditions in primary neuronal cell culture.
Gharibani PM; Modi J; Pan C; Menzie J; Ma Z; Chen PC; Tao R; Prentice H; Wu JY
Adv Exp Med Biol; 2013; 776():241-58. PubMed ID: 23392887
[TBL] [Abstract][Full Text] [Related]
16. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
Sonkusare SK; Kaul CL; Ramarao P
Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
[TBL] [Abstract][Full Text] [Related]
17. Excitotoxic neuroprotection and vulnerability with CaMKII inhibition.
Ashpole NM; Hudmon A
Mol Cell Neurosci; 2011 Apr; 46(4):720-30. PubMed ID: 21316454
[TBL] [Abstract][Full Text] [Related]
18. TRPing into excitotoxic neuronal death.
Green MV; West AE
Cell Calcium; 2021 Jan; 93():102331. PubMed ID: 33341523
[TBL] [Abstract][Full Text] [Related]
19. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults.
Lipton SA
NeuroRx; 2004 Jan; 1(1):101-10. PubMed ID: 15717010
[TBL] [Abstract][Full Text] [Related]
20. The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage.
Yoo SJ; Cho B; Lee D; Son G; Lee YB; Soo Han H; Kim E; Moon C; Moon C
Cell Death Dis; 2017 Aug; 8(8):e3003. PubMed ID: 28817120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
